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ABSTRACT 
 
Purpose:  To describe the microbiology results of corneal scrapings and morphology 
results of corneal ulcers over a one year period at the St John Eye Hospital with the 
following objectives:  (i) to describe the positive culture results (ii) to describe the 
commonest causative organisms (iii) to describe resistance patterns to antibiotics (iv) to 
correlate the positive culture results with the clinical characteristics of the ulcer. 
Methods:  A retrospective cross sectional review of patient medical records and 
microbiology reports of patients who presented with corneal ulcers at the St John Eye 
Hospital between October 2007 and October 2008.  One hundred and fifty one (151) 
corneal scrapings submitted to the National Health Laboratory Services (NHLS) for 
microbiology, culture and sensitivity testing were analyzed. The following information 
was extracted from the microbiology reports and patient medical records:  patient 
demographics, microbial isolations, antibiotic sensitivity and resistance,  and corneal 
ulcer morphology (central versus peripheral). 
Results:  Of the 151 patients who had corneal scrapings, 63(42%) were female and 
88(58%) were male.  The median age was 39.6(range 1-95; SD 19.3). An organism was 
identified in 78(52%) of the samples.  Of the 93 pathogens isolated, 78(83.9%) were 
gram positive, 10(10.8%) were gram negative, and 5(5.4%) were fungi. Mixed isolates 
were found in 15 of the 151 corneal scrapings. The most common gram positive isolates 
were Staphylococcus aureus 23(29.5%), coagulase negative Staphylococcus 18(23.1%), 
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and Streptococcus pneumoniae 16(20.5%).  The two most commonly isolated gram 
negative organisms were Pseudomonas aeruginosa 3(30%) and Haemophilus influenza 
3(30%). A total of 5 fungi were isolated from the 151 corneal scrapings with Fusarium  
3(60%) being the most common fungus isolated.  Antibiotic resistance patterns were as 
follows:  Gram positive isolates (73) consistently showed 100% sensitivity to 
vancomycin.  A small number of gram positive organisms showed in vitro  resistance to 
the second generation fluoroquinolone ciprofloxacin. This was, however only a small 
number of gram positive isolates and therefore the P value (P<0.001) remained 
significant.  Overall the gram positives isolates showed a 95.3% sensitivity to 
ciprofloxacin.   Both second and fourth generation fluoroquinolones, ciprofloxacin and 
moxifloxacin respectively, showed equivalent (100%) in vitro activity against the gram 
negative isolates. All  gram negative isolates showed 100% laboratory susceptibility to 
the aminoglycosides, gentamicin and amikacin.  Inpatient medical records were 
available for 56 of the 151 corneal ulcer scrapings. Of the 56 inpatient records reviewed 
42(75%) were central ulcers.  Streptococcus pneumoniae 10(23.8%) was the most 
common organism isolated in central corneal ulcers, while staphylococcus aureus 
4(28.6%) was the most common organism isolated in peripheral corneal ulcers.  
Conclusion:  Compared with previous reports from the St John Eye Hospital, the 
spectrum of causative organisms has remained unchanged over the past 25 years.  The 
organisms commonly responsible for microbial keratitis at the hospital are significantly 
susceptibility to the antibiotics currently being used as therapy. 
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Chapter 1 
 
In this chapter the background to the study will be described, as well as the overall 
research question and its importance. The chapter describes the field in which the 
research is based and the research question. The justification for the study will be 
stated.  The relevant literature related to the topic will be presented. The aims and 
objectives of the study will be stated. 
1. Introduction  
 
Microbial keratitis is defined as a stromal infiltrate associated with an overlying 
epithelial defect with or without an anterior chamber reaction.1   It is potentially 
blinding and is a major cause of ocular morbidity if appropriate treatment is not 
initiated promptly.  Intensive broad-spectrum therapy is usually started before 
laboratory culture results are available.2 It is widely accepted that the spectrum of 
microorganisms responsible for corneal ulceration varies in all geographic regions.2 It is 
therefore crucial that empiric antimicrobial treatment used is based on the prevalence 
of microorganisms in the community.2   
1.1 Problem statement 
 
There is increasing concern that the organisms responsible for bacterial keratitis are 
showing resistance to the current antimicrobials in widespread use.   
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1.2 Justification for the study 
 
The knowledge of the most common organisms in each region and their resistance 
patterns is of practical concern because of the difference in therapeutic approach. This 
study will show whether the more common organisms responsible for microbial keratitis 
in the specific setting of the St John Eye Hospital in Soweto, Johannesburg are still 
sensitive to the antimicrobials currently used. 
 
1.3 Background 
 
1.3.1 Anatomy and Physiology 
 
The transparent cornea forms the most anterior part of the globe and is the main 
structure responsible for the refraction of light entering the eye.  Microscopically five 
layers can be identified.  From anterior to posterior they are as follows (1) the 
epithelium (2) Bowman’s layer (membrane) (3) the stroma (4) Descemet’s membrane 
(5) the endothelium.3 
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    Figure 1.1:  Diagram showing the anatomy of the cornea3 
 
The corneal epithelium is composed of nonkeratinized, nonsecretory stratified 
squamous epithelium which is 4-6 layers thick.  A 7μm thick tear film covers the 
epithelium.  One of functions of the tear film is to protect the corneal surface from 
microbial invasion, as well as from chemical, toxic, or foreign body damage.4  Bowman’s 
layer lies beneath the basement membrane of the epithelium and is acellular and 
consists of interwoven collagen fibrils.3  The stroma forms 90% of the corneal thickness.  
It is transparent, fibrous and compact and consists of many lamellae of collagen fibrils. 
Descemet’s membrane lies on the posterior surface of the stroma and is the basement 
membrane of the endothelium. It is strong and homogenous and is composed of type IV 
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collagen fibrils.  The final layer is the endothelium which is made up of a single layer of 
flattened cells that are polygonal in shape.3  
 
1.3.2 Pathogenesis and clinical features 
 
Infectious keratitis is one of the leading causes of blindness, but, in most cases these 
infections represent preventable or treatable ophthalmic disease.  It is characterized by 
a cellular infiltration of the corneal epithelium or stroma, corneal inflammation, and 
necrosis.  Disruption of the continuity of the epithelium is the most common event that 
allows the establishment of a corneal infection. In this setting the keratitis may be 
caused by gram positive organisms such as staphylococci and streptococci, or gram 
negative organisms such as Pseudomonas aeruginosa or fungi such as Fusarium species.  
A few organisms such as Corynebacterium dipththeriae, Haemophilus aegyptius, 
Neisseria gonorrhoeae, Neisseria meningitides, Shigella and Listeria species can 
penetrate an intact epithelium. The clinical presentation of bacterial keratitis includes 
decreased vision, pain, and photophobia.  Ocular findings include a localized or diffuse 
infiltration of the epithelium or stroma, with epithelial absence.  Alternatively, a stromal 
abscess can occur beneath an intact epithelium.  Additional ocular features include lid 
oedema, conjunctival inflammation and chemosis, a discharge, and an anterior chamber 
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reaction.  The anterior chamber inflammation may be so severe as to produce a 
hypopyon. 4 
 
 
Figure 1.2 Corneal ulcer with a hypopyon (Courtesy of Professor T R Carmichael) 
 
1.4 Literature review 
 
One of the challenges faced when reviewing the current literature concerning microbial 
keratitis is the fact that not only does the incidence vary according to the geographic 
location, but there are regional variations in organism type and predominance as a 
result of patient populations and climatic effects. The following sections will attempt to 
review the status of the current literature on microbial keratitis. 
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1.4.1 Epidemiology 
 
The incidence of microbial keratitis varies according to the geographic location:  in the 
United States the incidence is 11 per 100,000 persons per year, whereas in Nepal it is 
799 per 100,000 persons per year.5 Longitudinal epidemiologic studies provide 
information with regard to the pattern of causative organisms, changing patient 
demographics, and their antibiotic sensitivities.5 
 
Several studies have found a male predominance when reviewing the demographic 
features of microbial keratitis.1,2,5  Keay et al found that 63.6% microbial keratitis cases 
were male. 1  In another study of microbial keratitis in Sydney a 52% male predominance 
was found.2  Likewise in a large retrospective study by Bharathi et al 1,879 (59.03%) 
were found to be  male and 1,304 (40.97%) were females, with a male to female ratio of 
1.44 to 1.  More than half of the patients (51.81%) were between the ages of 21 and 50 
years.5 
 
Ocular trauma and contact lens wear have been identified by several studies as the 
most common risk factor for microbial keratitis.1,2,5,6,7,8   Corneal infection among males 
could be attributed to their greater involvement in outdoor activities and outdoor 
occupations, thus making them prone to corneal injury with external agents.5 In South 
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Africa, corneal trauma is a common cause of microbial keratitis.6  Carmichael et al  
found a male predominance, half of whom were manual labourers.6  Bharathi et al have  
also shown that occupation played a role in the type of responsible organism.  
Agricultural workers were more in number among patients with fungal keratitis, 
whereas non-agricultural workers were more in number among patients with bacterial 
keratitis.5 
 
In first world countries the relatively high incidence of myopia and the popularity of 
contact-lens wear are commonly identified as the cause of microbial keratitis.  In a study 
by Saeed et al, the use of disposable contact lenses was the most important cause 
(59.5%) of cases of microbial keratitis in Ireland.8   Similarly, Keay et al found contact 
lens wear (33.7%) and trauma (36.4%) to be the two most commonly identified causes 
of microbial keratitis in Australia. They also found that of the traumatic cases, the 
majority were male (90.6%).1 
 
1.4.2 Microbiological profile 
 
The spectrum of microorganisms responsible for microbial keratitis varies in different 
geographical regions.9 These variations in organism type and predominance are as a 
result of different patient populations and climatic effects.5 
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In a longitudinal study at a major public hospital in Australia over a 5 year period, 
patient demographics, corneal culture results, and keratitis risk factors were studied.  A 
total of 253 corneal scrapings from 231 patients were included in the study.  Gram 
positive bacteria (29%) were the most common group of organisms of which 
Staphylococcus and Streptococcus genera were the most common isolates.  Of the Gram 
negative isolates (23%), Pseudomonas aeruginosa was the most common isolate.  A 
fungal cause was found in 12 (5%) of cases, and Fusarium was the most common 
species.10 They also found a significant variation in the monthly recovery of 
Pseudomonas aeruginosa and fungi which were cultured more frequently in the 
summer, whereas Streptococcus pneumoniae was more common in winter months than 
at other times of the year.10  
 
In tropical countries such as South India, the incidence of fungal keratitis is much higher. 
Bharathi et al  found that of the 3,183 patients with infective keratitis, 1,043 (33%) were 
bacterial, 1,095 (34%) were fungal , 33 (1%) were Acanthamoeba,  76 (2%) were both 
fungal and bacterial. The predominant bacterial pathogens isolated were Streptococcus 
pneumoniae (36%), while Fusarium species (42%) were the most common fungal 
pathogens isolated.5  
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In Taiwan, where the climate is subtropical, Pseudomonas species were the most 
commonly isolated organisms (38%), followed by fungi (14%), Staphylococci (8.4%), 
nontuberculous Mycobacteria (7.9%), and Streptococci (7.6%).9   
 
In the temperate South African climate, Cockinos et al found that of the 52 eyes with 
culture positive results,  30(79%) were gram positive and 8(21%) were gram negative.7   
Of the gram positives, Steptococcus pneumoniae and Staphylococcus epidermidis were 
found to be the predominant gram positives, whilst Pseudomonas aeruginosa was the 
most common gram negative isolated.7 
 
Therefore, the principle regional differences appear to be that filamentous fungal 
keratitis and gram negative keratitis are commonly seen in tropical climates, whereas 
gram positive bacteria are more common in temperate climates.5   
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                        Figure 1.3 Streptococcus pneumoniae ulcerative keratitis with a hypopyon (Courtesy of Professor T R 
Carmichael) 
 
1.4.3 Culture positive rate  
 
The rate of positive cultures can vary between studies. The main cause of a low positive 
culture rate is the frequent use of antibiotics before referral in the clinical setting.9   
Also, topical anesthetic agents are known to have antimicrobial properties and 
therefore their use may lead to false negative culture results.9 Table 1 below 
summarises the culture positive rate of studies carried out in different geographical 
regions.  Exposure to topical antimicrobial therapy before culture may result in a delay 
in pathogen recovery, but not in a difference in the rate of sterile samples.1 
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Table 1.1: Culture positive rate and organisms isolated in microbial cases in different regions 
 
 
South 
Africa6 
South 
Africa7 
 
Paraguay
11
 
 
South 
Florida12 
Australia
1
 Taiwan
13
 
 
Number of corneal 
scrapings 
 
 
283 
 
 
93 
 
660 
 
2920 
 
267 
 
501 
Culture positive rate 
 
66% 63% 79% 50% 49% 50.7% 
Most common pathogen 
isolated 
 
Gram 
positive 
Gram 
positive 
Gram 
positive 
Gram 
negative 
Gram 
Positive 
Gram 
negative 
 
To determine the causative organism, corneal ulcers are scraped for microscopy, culture 
and drug sensitivity.14 Microbial culture is slow, with growth and identification taking 
approximately three to five days for bacteria and even longer for fungi.15 Newer 
modalities for detection of microbial keratitis include molecular diagnostic techniques 
such as Polymerase Chain Reaction (PCR).15 Kim et al prospectively compared microbial 
culture and PCR in the diagnosis of corneal ulcer.  A total of 108 corneal ulcers were 
cultured and analyzed by PCR.  Of the 108 samples, 56 (51.9%) were culture-positive. 
After elimination of false-positive PCR products, 94 of 108 corneal scrapings (87%) were 
positive by PCR.15 The authors concluded that practical use of the technique is limited by 
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artefactual amplification of nonpathogenic organisms. They added that PCR may be 
used as an adjunct to culture to identify potential pathogens in microbial keratitis.15 
 
Microbial culture therefore remains the gold standard for the detection of pathogens 
causing corneal ulcers. Finally, apart from its diagnostic value, corneal scraping allows 
improved antibiotic penetration and therapeutic debridement of necrotic tissue.14 
 
1.4.4 Treatment 
 
Microbial keratitis should be treated as an ocular emergency due to its rapid 
progression and devastating complications.17 Empirical antimicrobial therapy should be 
promptly started and should be based on the prevalence of microorganisms in the 
community.2 The initial treatment regimen is usually a broad-spectrum antibiotic 
followed by more specific therapy once MC&S results of corneal scrapings become 
available.12   
 
In the early and mid-1980’s, the combinations of a cephalosporin(cefazolin) and an 
aminoglycoside (either gentamycin or tobramycin) were probably the most widely used 
therapeutic regimen for the initial treatment of infectious keratitis.18  The commercial 
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introduction of the second generation fluoroquinolones (ciprofloxacin and ofloxacin) led 
to the evaluation of the “standard” fortified eyedrop approach. Their appeal was the 
ease of administering a single antibiotic eyedrop without the need to prepare fortified 
drops and their wide gram positive and gram negative spectrum.18 The second 
generation fluoroquinolone ciprofloxacin has for many years been widely accepted for 
the first-line treatment of bacterial keratitis.19 
 
At the St John Eye Hospital in Soweto, South Africa, all patients with suspected microbial 
keratitis are empirically started on an intensive regimen of a broad-spectrum second 
generation fluoroquinolone, ciprofloxacin, and chloramphenicol ointment.  Treatment is 
then adjusted once culture sensitivity results are known. 
 
Past studies have shown that ciprofloxacin is effective against most bacterial keratitis. A 
retrospective study was undertaken by Cockinos and Carmichael at the St John Eye 
Hospital.7 They evaluated the management strategies of infectious keratitis as topical 
ciprofloxacin monotherapy had largely replaced the fortified antibiotic drops regimen 
which was previously used to treat bacterial keratitis.  Ciprofloxacin as empirical therapy 
was used successfully in 22 of the 24 patients.7 
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 Ly et al performed quantitative susceptibility testing to six antibiotics on all bacteria 
isolated from 112 patients who presented to the Sydney Eye Hospital Emergency 
Department with presumed bacterial keratitis.  Ninety per cent (90%) of coagulase-
negative Staphylococci were susceptible to ciprofloxacin.  Pseudomonas aeruginosa had 
a 100% susceptibility to gentamicin, tobramycin and ciprofloxacin.  Staphylococcus 
aureus strains showed 100% sensitivity to cephalothin, the aminoglycosides and 
ciprofloxacin.  All Streptococcal isolates were sensitive to cephalothin, chloramphenicol 
and ciprofloxacin, but showed resistance to the aminoglycosides.2 
 
Recently, studies have shown an emergence of resistance to the second generation 
fluoroquinolones.12 Emerging resistance of Staphylococcus aureus, Streptococcal species 
and Pseudomonas to the earlier generation fluoroquinolones has raised concern.17 The 
topical fourth generation fluoroquinolones (gatifloxacin and moxifloxacin) have recently 
been developed in response to the emerging resistance to the older generation of 
fluoroquinolones.17 Parmar et al showed that gatifloxacin had a significantly better 
action against gram positive cocci both in vitro and in vivo compared with 
ciprofloxacin.19 This finding is important since gram positive cocci are the most common 
causes of bacterial keratitis worldwide and therefore gatifloxacin may be a preferred 
alternative to cipfloxacin as the first-line monotherapy in bacterial keratitis.17 
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This emergence of drug resistance and availability of newer antimicrobials has made it 
essential for us to update our knowledge and review our treatment guidelines. 
 
1.4.5 Corneal ulcer morphology 
 
The morphology of a corneal ulcer is defined by the location of the principal infiltrate. 
The severity of corneal ulcers usually depends on the underlying condition of the cornea 
and the pathogenicity of the infecting organism.12  Bourcier et al looked at the clinical  
characteristics of bacterial keratitis.  Of the 300 cases with presumed bacterial keratitis 
examined, they found a predominance of the inferior cornea (46%) as the location for 
the principle corneal infiltrate.  They also found that central corneal ulcers made up 23% 
of the corneal infiltrate location, 24% and 22% made up the inferior nasal and temporal 
locations respectively, and only 4% of the infiltrates were diffuse.20 Carmichael et al 
found that central bacterial  ulcers caused by Streptococcus pneumoniae constituted the 
largest group of ulcers seen.  Staphylococcus aureas was the most common organism 
isolated from the marginal catarrhal group of ulcers as a result of chronic staphylococcal 
lid disease.6   
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Figure 1.4 Centrally located stromal necrotic Herpes simplex keratitis with a hypopyon and peripheral 
vascularization (Courtesy of Professor T R Carmichael) 
 
 
 
Figure 1.5 Peripheral ulcerative keratitis secondary to Neisseria gonorrhoeae (Courtesy of Professor TR 
Carmichael) 
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1.5   Research aim 
 
The aim of the study was to describe the microbiology results of corneal scrapings and 
morphology results of corneal ulcers over a one year period at the St John Eye Hospital. 
 
1.6   Research objectives 
 
Objectives: 
 To describe the positive culture results  
 To describe the commonest causative organism 
 To describe resistance patterns to antibiotics 
 To correlate the positive culture results with the clinical characteristics/ 
morphology of the ulcer 
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Chapter 2 
 
In this chapter the methodology of the study will be described.  The study design, the 
study population and the method of data collection will be described.  The management 
and analysis of the data will be described and ethical considerations will be mentioned. 
 
2.  Methodology 
2.1   Study design 
 
This was a retrospective cross sectional study of patient medical records and 
microbiological reports of patients who presented with corneal ulcers at the St John Eye 
Hospital between October 2007 and October 2008. 
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2.2 Data collection 
 
The data were collected in two stages. 
Review of microbiology reports: 
All patients’ microbiology reports of corneal scrapings were retrieved from the National 
Health Laboratory Services (NHLS).  This was done by searching the NHLS data base for 
all corneal scrapping specimens that were sent in for microbiology, culture and 
sensitivity (MC&S). The relevant information was extracted from the reports and 
recorded on the data capture sheet (appendix A).  This included patient demographics, 
the culture result and the antibiotic sensitivity and resistance. 
Review of inpatient medical records: 
The inpatient progress notes of all patients who were admitted for the treatment of 
their corneal ulcers were retrieved from the records room at St John Eye Hospital.  
Information extracted from the treating doctors notes related to the corneal 
morphology and was recorded on the data capture sheet (appendix A). For clinical 
features of the corneal ulcer, the location of the ulcer was classified into central or 
peripheral.  A central zone was defined as the central 5mm diameter of cornea.  The 
peripheral zone was the remaining annulus of cornea. 
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2.3 Study population 
 
This consisted of one hundred and fifty one (151) corneal scrapings sent in to the 
National Health Laboratory Services between October 2007 and October 2008 for 
microbiology, culture and sensitivity testing. 
 
2.4 Data management 
 
Each patient was assigned a unique number to ensure anonymity.  These unique case 
numbers were correlated to their microbiology reports and inpatient medical records.  
All patient information collected during the course of the research was kept strictly 
confidential and only information directly relevant to the study was extracted. 
Data from the data capture sheets were recorded in Microsoft Excel 2003.   
 
2.5 Data analysis 
 
The data were analyzed using STATA 10. Descriptive analysis was done using means to 
describe data normally distributed and mediums where the data were skewed. P-values 
were calculated to determine the statistical significance of the findings. 
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2.6 Ethical considerations 
 
Ethical approval was obtained from the Human Research Ethics Committee of the 
University of the Witwatersrand, Johannesburg.  The ethics protocol number is 
M090216 (Appendix B).  Information was kept strictly confidential. 
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Chapter 3 
3.  Results 
 
During the one year period from October 2007 and October 2008, 151 corneal scrapings 
microbiology results were retrieved from the National Health Laboratory Services.  
During this period 56 inpatient records were retrieved from the St John Eye Hospital 
records room.  
3.1 Patient demographics 
 
There were 151 records retrieved from the NHLS records and of these 88(58%) were 
males. The median age was 39.6(range 1-95; SD 19.3).  
 
The medical records of 56 patients admitted to the St John Eye Hospital for treatment of 
their corneal ulcers were reviewed for the same study period. Of the 56 inpatient 
records reviewed 37(66.1%) were male. The median age was 37.5(range 2-80; SD 18.6). 
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3.2 Culture yield 
 
There were 93 organisms isolated from the 151 corneal scrapings sent for MC&S. There 
was no growth in 73(48.3%) of the specimens. Mixed isolates were found in 15 
specimens. In the 78 specimens where there was growth 93 organisms were isolated. Of 
the 93 pathogens isolated, 78(83.9%) were gram positive, 10(10.8%) were gram 
negative and 5(5.4%) were fungi. 
3.3 Gram positive organisms 
 
Table 3.1 Number and types of gram positive organisms isolated from 151           
corneal scrapings 
Organism Number of isolates 
Staphylococcus aureus 23 
CNS* 18 
Streptococcus pneumoniae 16 
Streptococcus viridians   6 
Streptococcus pyogenes   4 
Corynebacterium species   3 
Staphylococcus epidermidis   3 
MRSA†   3 
Staphylococcus warrii   1 
Streptococcus milleri   1 
Total 78 
*Coagulase negative staphylococcus  
†Methicillin resistant staphylococcus aureus 
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A list of the gram positive organisms isolated from the 151 corneal scrapings is shown in 
Table 3.1.  The three most commonly isolated gram positive microorganism were 
staphylococcus aureus 23(29.5%) followed by coagulase negative staphylococcus 
18(23.1%) and streptococcus pneumoniae 16(20.5%). 
 
3.4 Gram negative organisms 
 
Table 3.2 outlines the 10 gram negative organisms isolated from the 151 corneal 
scrapings sent in for MC&S.  The two most commonly isolated gram negative organism 
were Pseudomonas aeruginosa 3(30%) and Haemophilus influenzae 3(30%).   
 
        Table 3.2 Number and type of gram negative organisms isolated from 151 corneal scrapings 
Organism Number of isolates 
Pseudomonas aeruginosa 3 
Haemophilus influenza 3 
Pantoea species 1 
Serratia marcescens 1 
Moraxella  1 
Proteus mirabilis 1 
Total 10 
25 | P a g e  
 
 
3.5 Fungi 
 
A total of 5(3%) fungi were isolated from the 151 corneal scrapings sent in for MC&S 
with Fusarium 3(60%) being the most common fungus isolated. 
              Table 3.3 Number and type of fungal pathogens isolated from 151 corneal scrapings 
Fungal isolate Number of isolates 
Fusarium  3 
Candida albicans 1 
Candida parapsilosis 1 
Total 5 
 
3.6 Antibiotic susceptibility: Gram positives 
 
Table 3.4 details the comparisons of the antibiotic susceptibilities of the more popular 
antibiotics used in the treatment of microbial keratitis.  Gram positive isolates (73) 
consistently showed 100% sensitivity to vancomycin.  A small number of gram positive 
organisms showed some in vitro resistance to the second generation fluoroquinolone 
ciprofloxacin: Methicillin resistant Staphylococcus aureus (3), Staphylococcus warrii (1) 
and streptococcus milleri (1).  This was, however, only a small number of gram positive 
isolates and therefore the P value (P<0.001) remained significant. Streptococcus 
pnemoniae demonstrated greatest susceptibility (100%) to Chloramphenicol than any 
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other gram positive organism. All of the 16 Strep. pneumoniae tested for susceptibility 
against the fourth generation fluoroquinolone moxifloxacin were 100% sensitive.  The 
third generation cephalosporin cefotaxime significantly (P=0.051) showed 100% 
laboratory activity against all the gram positive isolates. In contrast the second 
generation cephalosporin cefoxitin showed a statistically significant (P=0.005) resistant 
patterns to coagulase negative staphylococcus (17.6%) as well as a 42.9% resistance 
towards other gram positives such as MRSA, Staph. warrii and Strep. milleri. 
 
Table 3.4 Number and percentage of gram positive organism’s sensitivity profile 
Antibiotics Staph. 
Aureus 
CNS* Strep. 
 pneum. 
Strep.  
viridans 
Strep.  
pyogenes 
Other† 
Ciprofloxacin 
P=0.000 
22 
(100%) 
15 
(100%) 
‡ ‡ ‡ 4 
(66.7%) 
Moxifloxacin ‡ ‡ 16 
(100%) 
‡ ‡ ‡ 
Vancomycin 22 
(100%) 
17 
(100%) 
16 
(100%) 
6 
(100%) 
4 
(100%) 
8 
(100%) 
Chloramphenicol 
P=0.108 
17 
(89.5%) 
12 
(75.0%) 
13 
(100%) 
‡ ‡ 1 
(50%) 
Cefotaxime 
P=0.051 
1 
(100%) 
1 
(100%) 
‡ 4 
(100%) 
3 
(100%) 
1 
(100%) 
Cefoxitin 
P=0.005 
23 
(100%) 
14 
(82.4%) 
‡ 1 
(100%) 
‡ 4 
(57.1%) 
*Coagulase negative staphylococcus  
†Methicillin resistant staphylococcus aureus, Staphylococcus warrii, Streptococcus melleri  
‡Susceptibility testing not done 
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3.7 Antibiotic susceptibility: Gram negatives  
 
The susceptibility profile of the gram negative organisms isolated is shown in Table 3.5. 
Both second and fourth generation fluoroquinolones, ciprofloxacin and moxifloxacin 
respectively, showed equivalent (100%) in vitro activity against the gram negative 
isolates. All gram negative isolates exhibited 100% laboratory susceptibility to the 
aminoglycosides,  gentamicin and amikacin. Community acquired organisms such as 
Haemophilus influenzae showed 100% in vitro susceptibility against third generation 
cephalosporins, ceftazidine and cefotaxime. Pseudomonas aeruginosa, however, 
showed marked resistance (33.3%) against ceftazidine. 
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Table 3.5 Number and percentage of gram negative organism’s sensitivity profile 
Antibiotics Pseudo. 
aerug. 
Pantoea  
Species 
Proteus 
mirabilis 
Haem. 
 influen 
Serratia 
Marcescens 
Gentamicin 2 
(100%) 
1 
(100%) 
1 
(100%) 
* 1 
(100%) 
Amikacin 3 
(100%) 
1 
(100%) 
1 
(100%) 
* 1 
(100%) 
Chloramphenicol 
P=0.753 
* 1 
(100%) 
1 
(100%) 
2 
(66.7%) 
1 
(100%) 
Ciprofloxacin 3 
(100%) 
1 
(100%) 
1 
(100%) 
3 
(100%) 
1 
(100%) 
Moxifloxacin 1 
(100%) 
1 
(100%) 
* * * 
Ceftazidine 
P=0.817 
2 
(66.7%) 
1 
(100%) 
1 
(100%) 
1 
(100%) 
1 
(100%) 
Cefotaxime * 1 
(100%) 
1 
(100%) 
3 
(100%) 
1 
(100%) 
*Susceptibility testing not done 
 
3.8 Corneal ulcer morphology 
 
Inpatient medical records were available for 56 of the 151 corneal ulcer scrapings sent 
in for MC&S. In the 56 medical records reviewed 42 (75%) were central ulcers (involved 
the central 5mm of the cornea).  The organisms isolated from corneal scrapings of 
central and peripheral ulcers are shown in Table 3.6.  Streptococcus pneumoniae 
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10(23.8%) was the most common organism isolated in central corneal ulcers, while 
staphylococcus aureus 4(28.6%) was the most common organism isolated in peripheral 
corneal ulcers. Second to this was Staphylococcus epidermidis which was isolated in 
14.3% of peripheral corneal ulcers.  
 
A fungal isolate, Candida parapsilis, was found in 1(2.4%) of the central ulcers while 
scrapings taken from peripheral ulcers did not demonstrate any fungal growth.  In the 
56 medical records reviewed 17 (30.4%) cases were associated with a hypopyon and 15 
of these were central lesions. 
         Table 3.6 Number and type of organisms isolated from 56 central and peripheral ulcers 
Isolate Central ulcers n=42(%) Peripheral ulcers n=14(%) 
No growth 17 (40.5) 6 (42.9) 
Pseudomonas aeruginosa 1 (2.4) 0 
MRSA* 1 (2.4) 0 
Staph aureus 2 (4.8) 4 (28.6) 
CNS† 5 (11.9) 1 (7.1) 
Strep. Pneuemoniae 10 (23.8) 1 (7.1) 
Proteus mirabilis 1 (2.4) 0 
Strep viridians 3 (7.1) 0 
Staphylococcus warii 1 (2.4) 0 
Staph epidermidis 0 2 (14.3) 
Candida parapsilis 1 (2.4) 0 
           *Methicillin resistant staphylococcus aureus 
           †Coagulase negative staphylococcus  
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Chapter 4 
 
Discussion 
 
The St John Eye Hospital is the eye unit of the Chris Hani Baragwanath Hospital, a 
university hospital in Soweto.  St John serves the population of Soweto and is a referral 
centre for the greater Johannesburg.  The empirical approach in the treatment of 
microbial keratitis at St John is based on studies performed at the hospital over the past 
25 years.  This study sought to justify that approach since in the intervening time new 
antibiotics have emerged, antibiotic resistance has increased, and the high incidence of 
Human Immunodeficiency Virus (HIV) may have altered the prevalence pattern of 
microbials in the community. 
   
In this study, a male predominance was found similar to previous studies6,7,21  
conducted at the St John Eye Hospital.  Trauma has previously been reported as the 
most frequent cause for microbial keratitis at this hospital7,21 and this may still be the 
case.  As this was a retrospective review of patients’ medical records, data was not 
available regarding any predisposing factors leading to corneal ulceration.  
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Microorganisms were isolated in 78 (51.6%) of the 151 corneal scrapings in this study.  
This corresponds to many similar studies conducted globally in which positive growth is 
variable and occurs in 50-70% of cases.1,6,7,11,12,13 Despite the relatively low culture yield, 
microbial culture remains the gold standard for the detection of pathogens causing 
corneal ulcers as it is  highly specific.14,15  Newer modalities for detection of microbial 
keratitis  such as Polymerase Chain Reaction (PCR) is an alternative to standard 
microbiologic testing, but has its limitations.14  It yields a high rate of false positives for 
nonpathogenic organisms and is vulnerable to  airborne contamination.15   In some parts 
of the developing world the annual incidence of corneal ulceration has reached 
epidemic proportions.15 Practical use of the technique in a developing country such as 
South Africa will be limited by cost. Therefore, the practice of routine microbiological 
analysis for all corneal ulcers is still the investigation of choice at the St John Eye 
Hospital.  
 
The aetiology and epidemiology of corneal ulcers vary with the patient population, 
geographic location and climate, and tends to vary somewhat over time.5,9,10,22  South 
Africa’s weather is largely temperate and even more so at the high altitude of 
Johannesburg.  Of the 93 pathogens isolated in this study, 78(83.9%) were gram 
positive, 10(10.8%) were gram negative and 5(5.4%) were fungi. The most commonly 
isolated gram positive bacterium was Staphylococcus aureus (29.5%). Pseudomonas 
aeruginosa (30%) and Haemophilus influenzae (30%) were the two most common gram 
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negative organisms isolated. Of the fungi, Fusarium (60%) was the most common fungus 
isolated.  This microbial profile is in keeping with the cooler temperate climate found in 
Johannesburg.  Similarly, in certain regions of Australia, gram positives followed by gram 
negatives are the most commonly isolated organisms responsible for microbial 
keratitis.1,10 This is in contrast to tropical regions such as South India5, Taiwan9, 
Thailand22 and Ghana23, where Pseudomonas and Fusarium species are the most 
common causes of bacterial and fungal keratitis respectively.  Pseudomonas aeruginosa 
is also more likely to be isolated from contact lens-related keratitis in areas with higher 
maximum and minimum temperatures.24   
 
Empiric antimicrobial treatment may be used based on the prevalence of 
microorganisms in the community. The initial treatment regimen is usually broad-
spectrum intensive treatment followed by more specific therapy once MC&S results of 
corneal scrapings become available.12   One hundred percent of gram positive organisms 
isolated from the 151 corneal scrapings showed susceptibility to vancomycin.  Of the 
gram positives, Streptococcus pneumoniae was the only organism which showed 100% 
sensitivity to chloramphenicol (P=0.108).  Thirty seven of forty one gram positives 
showed 100% sensitivity to the second generation ciprofloxacin. Overall the gram 
positive isolates showed 95.3% sensitivity to ciprofloxacin. Ciprofloxacin previously 
found widespread acceptance for the treatment of bacterial keratitis,2,19 however, some 
studies have shown an emergence of resistance to the second generation 
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fluoroquinolones.12 This is important as gram positive bacteria made up 83.9% of the 
pathogens isolated in this study. Several studies have compared the bacteriologic and 
clinical efficacy of second generation and fourth generation fluoroquinolones.  Kowalski 
et al showed that the fourth generation fluoroquinolones had increased susceptibility 
for staphylococcus aureus isolates that were resistant to second generation 
fluoroquinolones ciprofloxacin and ofloxacin and to the third generation 
fluoroquinolone levofloxacin.25 Alexandrakis et al showed a three fold increase in the 
percentage of  the second generation fluoroquinolones ofloxacin and ciprofloxacin 
resistant  S. aureus isolates over their entire study period (11% in 1990 vs. 28%  in 
1998).12 Similarly Mather et al showed that the fourth generation fluoroquinolones 
were more  potent than second and third generation fluoroquinolones  for gram 
positive bacteria and were equally potent for gram negative bacteria.26 Since an older 
generation of fluoroquinolone, ciprofloxacin, is used as part of our empirical treatment 
regimen at the St John Eye Hospital, it is imperative that we continue to monitor the in 
vitro performance of this antimicrobial. The newer fourth generation fluoroquinolones 
(moxifloxacin and gatifloxacin) are not available at our hospital for routine treatment of 
corneal ulcers.  Judicious use of them is needed to avoid future bacterial resistance.   
 
The modern role of fortified antibiotics in the treatment of bacterial keratitis has been 
evaluated by several studies.2,27 This study  showed that the fortified third generation 
cephalosporin (cefotaxime) has 100% statistically significant (P=0.051) activity towards 
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gram positives compared to the second generation cephalosporin cefoxitin which 
showed an overall 87.5% activity towards gram positive cocci.  First  generation 
cephalosporins have a narrower spectrum of antibacterial activity than second or third 
generation cephalosporins.27 Second and third generation cephalosporins also have a 
broader spectrum against gram negative bacteria.26 Fortified antibiotics, however, have 
a number of disadvantages when compared to the fluoroquinolones.23  They are more 
expensive, need to be prepared, require refrigeration, have a shorter half life and are 
more toxic.17,27  Ganopadhyay et al found no significant treatment difference between 
fluoroquinolone and fortified therapy in terms of final visual outcome, but concluded 
that fluoroquinolones have the advantage of decreased toxicity and duration of 
treatment.27  As preferred practice at our hospital, fortified antibiotics are started when 
laboratory results show microbial resistance to ciprofloxacin. The choice of fortified 
antibiotic depends on the organism cultured and its sensitivity pattern. 
 
During the one year period of this study aminoglycosides consistently showed a 100% 
activity towards the gram negative isolates.  As fortified antibiotics the aminoglycosides 
give excellent gram negative coverage and are also active against staphylococci and 
some streptococci, but not against pneumococci.22 Once again moxifloxacin showed 
100% susceptibility to the gram negatives.  
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The inpatient records of 56 of the 151 corneal scraping patients were retrieved from the 
records room. Staphylococci were mostly isolated from peripheral corneal ulcers.  This 
may be secondary to the huge number of untreated staphylococcal lid disease seen in 
Africa.6,7,21   Once again Streptococcus pneumoniae was by far the most common 
pathogen isolated from central ulcers.7 
 
As with all retrospective studies, there are several shortcomings to this study. The first 
limitation is that it is cross sectional and therefore causality cannot be determined. 
Often a clue to identifying the most likely causative organism lies in the knowing of the 
patient’s predisposing factors. Ocular trauma, ocular surface disease, and contact lens 
wear are major predisposing causes of corneal ulceration and important in the clinical 
diagnosis of the causative organism.22 Another possible limitation is the relatively small 
sample size. Many of the more popular antibiotics used in the treatment of microbial 
keratitis were tested against a small number of organisms in vitro. This resulted in a few 
significant P- values. Another shortcoming is that the results can only be generalised to 
the source of the study and not to the general population.  Previous studies conducted 
at this hospital have also used the population of greater Johannesburg and Soweto as 
their study group.6,7,21   This study defines the pattern of keratitis in the same population 
group.  Perhaps a study of microbial keratitis in another region of South Africa would 
reveal a different microbial profile.  Finally, data on visual and clinical outcome was not 
included in this study and therefore treatment recommendations cannot be made. 
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Conclusion 
 
Microbiology, culture and sensitivity (MC&S) remains the gold standard for the 
identification of pathogens causing microbial keratitis.14,15 Factors such as ulcer size, 
operator skill in producing a quality sample, and culture technique are a few reasons for 
the low culture yield. Culturing, however, allows sensitivity testing so that treatment 
modifications can be made in an informed manner if the clinical response to the initial 
treatment is inadequate. The newer generation of fluoroquinolones is likely to play an 
important role in the future treatment of microbial keratitis because of an increasing 
resistance to the second generation fluoroquinolones currently being used.  This study, 
however, has shown that the commonly cultured microorganisms are still significantly 
sensitive to the second generation fluoroquinolone ciprofloxacin.  It is therefore still 
justifiable that it be used for treatment of suspected bacterial keratitis as first line 
empirical therapy.  
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Appendix A:  Data Capturing Sheet  
 
1.  Corneal scraping sample number  
2.  Gender  
3.  Age  
4.  Organism identified: 
4.1  Gram positive bacteria 
4.2  Gram negative bacteria 
         4.3  Mixed isolates 
4.4  Fungi 
4.5  Contaminant 
4.6  Sterile/Culture Negative 
 
5.  Antibiotic Susceptibility: 
          5.1  Amikacin 
5.2  Ampicillin/Pen 
5.3  Cefazolin 
5.4  Cefepime 
5.5  Cefotaxime 
5.6  Cefoxitin 
5.7  Ceftazidime 
5.8  Cefuroxime 
5.9  Chloramphenicol 
5.10 Ciprofloxacin 
5.11 Clindamycin 
5.12 Co-amoxiclav 
5.13 Colistin 
5.14 Cotrimoxazole 
5.15 Ertapenem 
5.16 Erythromycin 
Sensitive or Resistant: 
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5.17 Fusidic Acid 
5.18 Gentamycin 
5.19 Imipenem 
5.20 Linezolid 
5.21 Meropenem 
5.22 Minocycline 
5.23 Moxifloxacin 
5.24 Nalidixic Acid 
5.25 Pip-Taz 
5.26 Rifampicin 
5.27 Streptomycin 
5.28 Synercid 
5.29 Telithromycin 
5.30 Tetracycline 
5.31 Tobramycin 
5.32 Vancomycin   
6.  Culture morphology: 
 
 
 
 
 
 
Central 
5mm 
cornea
Peripheral 
cornea
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